(Q44210460)

30 November 2017

Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation (English)

1 reference

30 November 2017

Kleinhans M

1

1 reference

30 November 2017

Linzbach L

2

1 reference

30 November 2017

Zedlitz S

3

1 reference

30 November 2017

Kaufmann R

4

1 reference

30 November 2017

Boehncke WH

5

1 reference

30 November 2017

language of work or name

1 reference

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

47

1 reference

30 November 2017

2

1 reference

30 November 2017

100-102

1 reference

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

30 November 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

Fatal allergic vasculitis associated with celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

Tolerability of a selective cyclooxygenase-2-inhibitor (rofecoxib) in patients with intolerance reactions to nonsteroidal anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

inferred from DOI database lookup

7 January 2021

based on heuristic

COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0536.2002.470208.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-0536.2002.470208.X

1 reference

30 November 2017

1 reference